/Investor DB

Alamo Angels — Full Portfolio

3 tracked investments · listed companies and verified rows first

Arpeggio Bioarpeggiobio.comin𝕏Series A · Sep 2022 · $17M

Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.

BiotechHealthtechBoulder, US

Joey Azofeifa(Founder)inLaura Norris(Executive Officer, Director)inTimothy Read(Executive Officer, Director)Eric Martin(Executive Officer)in

BoardAmit Mehta(Director)

Co-investorsATEM Capital FundFifty YearsFundersClubTau VenturesvenBio PartnersY Combinator+9 more

Darkhivedarkhive.comApr 2026 · $30M

Darkhive builds integrated defense hardware and software solutions for military operations, including uncrewed systems, human-machine interfaces, and software platforms designed to enable rapid adaptation and mission success on the modern battlefield.

Defense TechHardwareSan Antonio, US

John Goodson(Executive Officer, Director)

BoardMatt Bigge(Director)inMark Hatfield(Director)inSteven Turner(Director)

Co-investorsCapital FactoryDraper AssociatesMVP VenturesTen ElevenBison CapitalCrosslink Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

The Betel Leaf Co.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.